Biblio
.
A d-peptide-based oral nanotherapeutic modulates the PD-1/PD-L1 interaction for tumor immunotherapy. Front Immunol. 2023;14:1228581.
. A dual-targeting supramolecular self-assembly peptide against pulmonary metastasis of melanoma. Theranostics. 2023;13(11):3844-3855.
. . .
.
.